Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration‐resistant prostate cancer
暂无分享，去创建一个
S. Steinberg | J. Trepel | W. Figg | Clara C. Chen | R. Madan | N. Dawson | W. Dahut | D. Mcleod | M. Theoret | Y. Tomita | Min-Jung Lee | J. Gulley | Sunmin Lee | B. Adesunloye | I. Rosner | Shaunna L. Beedie | T. Sissung | P. Arlen | F. Karzai | N. Harold | G. Chun | L. Cordes | Y. Ning | Xuan Huang | A. Couvillon